After a challenging first quarter of 2021 for biotech investors, what does the second quarter – and, beyond that, the second half of 2021 – have in store? Today’s article examines the investment opportunities the space offers at both ends of the disease prevalence spectrum, as well as the potential risks at play. For more, CLICK HERE.
Biotech Opportunities And Risks In Q2 – And Beyond
Tags:2021 First Quarter2021 Second QuarterBiotech InvestorsBiotech OpportunitiesInvestInvestingInvestment OpportunitiesPotential RisksStock Plays